Dr Matthew Ng
is a medical oncologist at the National Cancer Centre Singapore subspecialising in GI cancers and drug development. He was trained in the UK at the Royal Marsden Hospital and obtained a PhD from the Institute of Cancer Research (London) in pharmacology working on alpha-folate receptor-targeted therapy.
Currently he is the deputy director of the Investigational Medicine Unit at Singhealth and principal investigator of several sponsored and investigator-initiated Phase I-II trials as well as Phase III trials in gastric cancers. His research interests are in developing novel therapies for oesophageal and gastric cancers.